A Hard Look: How Did China Pharma Growth Fall So Fast, So Steeply?
This article was originally published in PharmAsia News
Executive Summary
While many are still shocked by the double-digit drop in quarterly pharma sales in the world’s second-largest economy, the underlying factors for the fast deterioration in China have in fact been brewing for some time and are multi-faceted, Yang Dongsheng of the R&D based Pharmaceutical Association Committee (RDPAC) tells PharmAsia News in an exclusive interview.